Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.06% Nasdaq Down0.01%

Novartis AG (NVS)

-NYSE

74.36 Up 0.54(0.73%) May 24, 4:02PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 57,561,000   59,375,000   51,561,000  
Cost of Revenue18,756,000  18,983,000  14,488,000  
Gross Profit 38,805,000   40,392,000   37,073,000  
Operating Expenses
Research Development9,332,000  9,583,000  9,070,000  
Selling General and Administrative17,962,000  19,811,000  16,477,000  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 11,511,000   10,998,000   11,526,000  
Income from Continuing Operations
Total Other Income/Expenses Net(96,000)(2,000)64,000  
Earnings Before Interest And Taxes11,967,000  11,524,000  12,394,000  
Interest Expense724,000  751,000  692,000  
Income Before Tax11,243,000  10,773,000  11,702,000  
Income Tax Expense1,625,000  1,528,000  1,733,000  
Minority Interest -   -   -  
Net Income From Continuing Ops10,170,000  9,773,000  10,773,000  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 9,618,000   9,245,000   9,969,000  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 9,618,000   9,245,000   9,969,000  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.